Arnoud van’t Hof

Early or late intervention in high-risk non-ST-elevation acute coronary syndromes: results of the ELISA-3 trial

• Badings E,
• The S,
• Dambrink J-H,
• van Wijngaarden J,
• Tjeerdsma G,
• Rasoul S,
• Timmer J,
• van der Wielen M,
• Lok D,
• van’t Hof A

EuroIntervention 2013;9:54-61

Published in Volume 9 Number 1, May 2013

Time-related impact of distal embolisation on myocardial perfusion and survival among patients undergoing primary angioplasty with glycoprotein IIb-IIIa inhibitors: insights from the EGYPT cooperation

• De Luca G,
• Gibson C,
• Huber K,
• Dudek D,
• Cutlip D,
• Zeymer U,
• Gyöngyösi M,
• Bellandi F,
• Noc M,
• Arntz H-R,
• Maioli M,
• Secco G,
• Zorman S,
• Gabriel H,
• Emre A,
• Rakowski T,
• van’t Hof A

EuroIntervention 2012;8:470-476

Published in Volume 8 Number 4, August 2012

Higher efficacy of pre-hospital tirofiban with longer pre-treatment time to primary PCI: protection for the negative impact of time delay

• Heestermans A,
• de Boer M,
• van Werkum J,
• Mosterd A,
• Gosselink A,
• Dambrink J,
• Van Houwelingen G,
• Koopmans P,
• Hamm C,
• Zijlstra F,
• ten Berg JM,
• van’t Hof A

EuroIntervention 2011;7:442-448

Published in Volume 7 Number 4, August 2011

HEBE-III randomised trial: A Zwolle sub-study with the Genous stent

• Suryapranata H,
• Ottervanger J,
• van’t Hof A,
• Hoorntje J,
• Dambrink J,
• Gosselink A,
• De Boer M

Published in Volume 7 Supplement M, May 2011

Triggering mechanisms of stent thrombosis

• Zwart B,
• van Werkum J,
• Heestermans A,
• Kelder J,
• Zomer A,
• van’t Hof A,
• Verheugt F,
• ten Berg JM

EuroIntervention 2011;6:722-728 published online ahead of print August 2010

Published in Volume 6 Number 6, January 2011

Pre-hospital administration of tirofiban in diabetic patients with ST-elevation myocardial infarction undergoing primary angioplasty: a sub-analysis of the On-Time 2 trial

• Timmer J,
• ten Berg JM,
• Heestermans A,
• Dill T,
• van Werkum J,
• Dambrink J,
• Suryapranata H,
• Ottervanger J,
• Hamm C,
• van’t Hof A

EuroIntervention 2010;6:336-342

Published in Volume 6 Number 3, August 2010

Incidence, predictors and prognostic importance of bleeding after primary PCI for ST-elevation myocardial infarction

• de Boer M,
• Hoorntje J,
• Gosselink A,
• Suryapranata H,
• van’t Hof A

EuroIntervention 2010;6:106-111

Published in Volume 6 Number 1, May 2010

Non-culprit lesions detected during primary PCI: treat invasively or follow the guidelines?

• Dambrink J,
• Debrauwere J,
• van’t Hof A,
• Ottervanger J,
• Gosselink M,
• Hoorntje J,
• de Boer M,
• Suryapranata H

EuroIntervention 2010;5:968-975

Published in Volume 5 Number 8, April 2010

How to set up an effective national primary angioplasty network: lessons learned from five European countries

• Knot J,
• Widimsky P,
• Wijns W,
• Stenestrand U,
• Kristensen S,
• van’t Hof A,
• Weidinger F,
• Janzon M,
• Nörgaard B,
• Soerensen J,
• van de Wetering H,
• Thygesen K,
• Bergsten P,
• Digerfeldt C,
• Potgieter A,
• Tomer N,
• Fajadet J

EuroIntervention 2009;5:299-309

Published in Volume 5 Number 3, August 2009

Ongoing tirofiban in myocardial infarction evaluation (On-TIME) 2 trial: rationale and study design

• van’t Hof A,
• Hamm C,
• Rasoul S,
• Gupthan S,
• Paolini J,
• ten Berg J

EuroInterv.2007;3:371-380

Published in Volume 3 Number 3, November 2007